326 related articles for article (PubMed ID: 10925964)
1. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease.
Marcinkiewicz M; Han K; Zbroch T; Poplawski C; Gramley W; Goldin G; Sarosiek J
Am J Gastroenterol; 2000 Jul; 95(7):1652-60. PubMed ID: 10925964
[TBL] [Abstract][Full Text] [Related]
2. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.
Rourk RM; Namiot Z; Edmunds MC; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Aug; 89(8):1177-84. PubMed ID: 8053431
[TBL] [Abstract][Full Text] [Related]
3. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.
Rourk RM; Namiot Z; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Feb; 89(2):237-44. PubMed ID: 8304310
[TBL] [Abstract][Full Text] [Related]
4. Modulatory impact of acid and pepsin on esophageal hydrophobicity in humans.
DeRosa J; Marcinkiewicz M; Sarosiek J; Edmunds M; McCallum RW
Am J Gastroenterol; 1995 Nov; 90(11):2020-4. PubMed ID: 7485014
[TBL] [Abstract][Full Text] [Related]
5. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
[TBL] [Abstract][Full Text] [Related]
6. Impact of acid and pepsin on human esophageal prostaglandins.
Sarosiek J; Yu Z; Namiot Z; Rourk RM; Hetzel DP; McCallum RW
Am J Gastroenterol; 1994 Apr; 89(4):588-94. PubMed ID: 8147363
[TBL] [Abstract][Full Text] [Related]
7. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
8. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.
Isomoto H; Saenko VA; Kanazawa Y; Nishi Y; Ohtsuru A; Inoue K; Akazawa Y; Takeshima F; Omagari K; Miyazaki M; Mizuta Y; Murata I; Yamashita S; Kohno S
Am J Gastroenterol; 2004 Apr; 99(4):589-97. PubMed ID: 15089887
[TBL] [Abstract][Full Text] [Related]
10. Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans.
Sarosiek J; Hetzel DP; Yu Z; Piascik R; Li L; Rourk RM; McCallum RW
Am J Gastroenterol; 1993 Jul; 88(7):1081-7. PubMed ID: 8317410
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
12. [Effect of chronic restraint stress on esophageal epithelial barrier function: experiment with rats].
Zhao DY; Duan LP; Zhu YL; Li ZQ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1837-40. PubMed ID: 19040020
[TBL] [Abstract][Full Text] [Related]
13. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.
Rantanen TK; Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Am J Gastroenterol; 2006 Feb; 101(2):222-8. PubMed ID: 16454822
[TBL] [Abstract][Full Text] [Related]
14. [Roles of bile and gastrin in the pathogenesis of childhood gastroesophageal reflux disease].
Wei JR; Jin RM; Zhou SM; Luo HY; Wang L; Bai DM; Li CR
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):287-90. PubMed ID: 16923358
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
Wex T; Mönkemüller K; Kuester D; Weise S; Kropf S; Fry LC; Stahr A; Völkel S; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
[TBL] [Abstract][Full Text] [Related]
16. Improving the analysis of esophageal acid exposure by a new parameter: area under H+.
Rebecchi F; Di FI; Giaccone C; Morino M
Am J Gastroenterol; 2002 Mar; 97(3):568-74. PubMed ID: 11922548
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.
Yoshida N; Uchiyama K; Kuroda M; Sakuma K; Kokura S; Ichikawa H; Naito Y; Takemura T; Yoshikawa T; Okanoue T
Scand J Gastroenterol; 2004 Sep; 39(9):816-22. PubMed ID: 15513378
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of oesophageal mucosal defence.
Sarosiek J; McCallum RW
Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct; 14(5):701-17. PubMed ID: 11003804
[TBL] [Abstract][Full Text] [Related]
19. What is the secretory potential of submucosal mucous glands within the human gullet in health and disease?
Sarosiek J; McCallum RW
Digestion; 1995; 56 Suppl 1():15-23. PubMed ID: 7556966
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD)].
Gómez-Escudero O; Remes-Troche JM; Ruíz JC; Peláez-Luna M; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):16-23. PubMed ID: 15193059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
